High materiality7/10
Acadia Pharmaceuticals price target raised to $37 from $32 at Deutsche Bank
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Deutsche Bank raises ACAD target to $37; current price $25.06; price +1.17 since signal.
- DB raises ACAD target to $37; price $25.06; +1.17 since signal.
Key facts
- 01
Target: $37
- 02
Posted price: $25.06
- 03
Analyst firm: Deutsche Bank
- 04
Analyst: David Hoang
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.